Skip to content

Assessment of Plasma Lactate in Non-cardiac Surgery Monitoring by Transthoracic Echocardiography

Assessment of Plasma Lactate in Patients Underwent Non-cardiac Surgery Monitoring by Transthoracic Echocardiography

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03103373
Enrollment
60
Registered
2017-04-06
Start date
2017-02-01
Completion date
2018-01-01
Last updated
2017-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Keywords

Echocardiography, anesthesia, general surgery

Brief summary

The study is a clinical trial, prospective and randomized of 60 patients of both genders, aged between 18 and 80 years, underwent major abdominal surgery. This study aims to compare plasma lactate levels in patients underwent major abdominal surgery (colectomy, gastrectomy, esophagectomy, pancreatectomy, Wertheim Meigs, liver and spleen surgeries) monitored by echocardiography or by conventional techniques (mean arterial pressure , Central venous pressure).

Detailed description

The study is a clinical trial, prospective and randomized of 60 patients of both genders, aged between 18 and 80 years, underwent major abdominal surgery. This study aims to compare plasma lactate levels in patients underwent major abdominal surgery (colectomy, gastrectomy, esophagectomy, pancreatectomy, Wertheim Meigs, liver and spleen surgeries) monitored by echocardiography or by conventional techniques (mean arterial pressure , Central venous pressure). The investigators expect to observe a decrease in plasma lactate levels in patients submitted to echocardiographic monitoring when compared to patients submitted to conventional monitoring. In this way, to demonstrate that the routine use of transthoracic echocardiography in patients submitted to large surgery improves the clinical outcomes of these patients and presents a lower hospital cost. The surgical indication will obey the criteria of the Federal University of Juiz de Fora surgery service, after clinical examination and routine preoperative laboratory tests (complete blood count, complete coagulogram, plasma sodium, potassium Plasma urea and plasma creatinine, blood glucose and liver function test), resting electrocardiogram and chest X-ray. All patients who agree to participate in the study will sign an Informed Consent Term in the preanesthetic evaluation (Appendix 1). Patients will be computer randomly form by the GraphPad Prisma® program into two groups with 30 patients: Conventional Group, Transthoracic Echocardiogram Group, All survey data will be noted in the Protocol Data Sheet (Appendix 2). Patients will be anesthetized by the researcher Dr. Marcello Fonseca Salgado Filho, who will also be responsible for performing the intraoperative TTE examination.

Interventions

DEVICEConventional monitor

Patients underwent non-cardiac surgery will be monitoring by regular monitors

DEVICEEchocardiography

Patients will be monitoring by regular monitors plus echocardiography

Sponsors

Federal University of Juiz de Fora
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

The study is a clinical trial, prospective and random type, in which 60 patients, of both genders, aged between 18 and 80 years, who will undergo major abdominal surgery, divided in two groups. Patients will be randomly divided into two groups with 35 patients: Conventional Group, Transthoracic Echocardiogram Group

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

ages between 18 and 80 years. * both genders * Large abdominal surgeries * Elective surgeries

Exclusion criteria

* Emergency surgeries * Surgeries of the abdominal aorta * Ejection fraction \<30% * Blood creatinine levels\> 2.0mg / dl * Glycemia\> 200 g / dl * Do not agree to participate in the study * Bowel obstruction * Sepsis * Bilirubin\> 300 g / dl * Alcoholism

Design outcomes

Primary

MeasureTime frameDescription
plasma lactate10 minutes after intubation, before incisionThe plasma lactate will be collected in the arterial line

Secondary

MeasureTime frameDescription
Assessment blood pressure10 minutes after intubation, before incisionblood pressure
Assessment venus oximetry10 minutes after intubation, before incisionvenus oximetry
Assessment arterial PH10 minutes after intubation, before incisionarterial PH
Assessment heart rate10 minutes after intubation, before incisionHeart rate
Infection30 days after surgeryAssessment sepsis
Surgery complications30 days after surgeryAssessment fistulae
Post-operative mortality30 days after surgerydeath after surgery
Assessment fluid infusion10 min after the end of the surgeryfluid infusion

Countries

Brazil

Contacts

Primary ContactMarcello F Salgado Filho, PhD
mfonsecasalgado@hotmail.com+5532999858833
Backup ContactIzabela P Silva, MsC
izabelapalitot@hotmail.com+5532991152615

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026